期刊文献+

病理性近视眼脉络膜新生血管治疗的研究进展 被引量:3

原文传递
导出
摘要 脉络膜新生血管形成(choroidal neovascularization,CNV)是威胁病理性近视眼患者视力的主要原因。近年来针对病理性近视眼CNV的治疗除采用光动力疗法外,还采用包括玻璃体注射抗血管内皮生长因子药物,以及联合玻璃体注射曲安奈德等方法来防治CNV的发生。未来的趋势可能是多种治疗方法联合应用,求得最大疗效同时,尽可能减少治疗的并发症。
出处 《国际眼科纵览》 2010年第5期338-342,共5页 International Review of Ophthalmology
基金 国家自然科学基金(81072843)
  • 相关文献

参考文献39

  • 1Xu L,Li Y,Wang S.Characteristics of highly myopic eyes:the Beijing Eye Study.Ophthalmology,2007,114:121-126.
  • 2Hsu SL,Chang CH,Lai YH,et al.Refractive status of mountain aborigine schoolchildren in southern Taiwan.Kaohsiung J Med Sci,2008,24:120-125.
  • 3Dirani M,Chan YH,Gazzard G,et al.Prevalence of refractive error in Singapore Chinese children:the strabismus,amblyopia,and refractive error in young Singaporean children(STARS) study.Invest Ophthalmol Vis Sci,2010,51:1348-1355.
  • 4Yamada M,Hiratsuka Y,Roberts CB,et al.Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections.Ophthalmic Epidemiol,2010,17:50-57.
  • 5Nangia V,Jonas JB,Sinha A,et al.Refractive error in central Indian:The Central India Eye and Medical Study.Ophthalmology,2010,117:693-699.
  • 6Hampton GR,Kohen D,Bird AC.Visual prognosis of disciform degeneration in myopia.Ophthalmology,1983,90:923-926.
  • 7Parodi MB,Lacono P,Papayannis A,et al.Laser photocoagulation,photodynamic therapy,and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.Arch Ophthalmol,2010,128:437-442.
  • 8Nabawi KS,Shaarawi AS.Transpupillary thermotherapy of subfoveal choroidal neovascularization secondary to pathologic myopia.Ophthalmic Surg Lasers Imaging,2010,41:12-17.
  • 9Montero JA,Ruiz-Moreno JM.Treatment of choroidal neovascularization in high myopia.Curr Drug Targets,2010,11:630-644.
  • 10Yamada Y,Miyamura N,Suzuma K,et al.Long-term follow-up of full macular translocation for choroidal neovascularization.Am J Ophthalmol,2010,149:453-457.

二级参考文献17

  • 1Green WR, Wilson DJ. Choroidal neovascularization. Ophthalmology, 1986, 93 : 1169-1176.
  • 2Kaiser PK, Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension TAP report No. 8. Graefe's Arch Clin Exp Ophthalmol, 2006, 244 : 1132-1142.
  • 3VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2001, 131 : 541-560.
  • 4Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Ophthalmology, 2006, 113:2002-2011.
  • 5Avery RL, Pieramici DJ, Ravena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-Related macular degeneration. Ophthalmology, 2006,113:363-372.
  • 6Krzystolik MG, Mshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch Ophthalmol, 2002, 120:338-346.
  • 7Chakravarthy U, Soubrane G, Bandello F, et al. Evolving European guidance on the medical management of neovascular age related macular degeneration. Br J Ophthalmol, 2006, 90:1188- 1196.
  • 8Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med, 2004, 351:2805-2816.
  • 9Garcia CA, Quiroz-Mercado H, Uwaydat S, et al. A phase Ⅰ/Ⅱ trial of intravenous squalamine lactate for treatment of choroidal neovascularization in age related macular degeneration (ARMD). Invest Ophthalmol Vis Sci ,2004, 45:2362.
  • 10Saishin Y, Saishin Y, Takahashi K, et al. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol, 2003, 195 : 241-248.

共引文献2

同被引文献17

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部